{"id":53936,"date":"2022-10-13T18:28:35","date_gmt":"2022-10-13T22:28:35","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=53936"},"modified":"2024-09-10T13:08:13","modified_gmt":"2024-09-10T17:08:13","slug":"synjardy-alternatives","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/synjardy-alternatives\/","title":{"rendered":"Synjardy alternatives: What can I take instead of Synjardy?"},"content":{"rendered":"

Compare Synjardy alternatives<\/a> | <\/span>Synjardy XR<\/span><\/a> | Glyxambi<\/a> | Trijardy XR<\/a> | Ozempic<\/a> | Janumet<\/a> | Natural alternatives<\/a> | How to switch meds<\/a><\/span><\/p>\n

Elevated blohttp:\/\/3synjardy-xrod sugar in <\/span>Type 2 diabetes mellitus<\/span> <\/a>arises from multiple mechanisms, including both low levels of natural <\/span>insulin<\/span><\/a> production and low responsiveness to it. Using multiple mechanisms to treat the disease makes perfect sense. Doing so with one drug seems ideal. <\/span>Synjardy<\/span><\/a> does so by combining <\/span>empagliflozin<\/span> and <\/span>metformin<\/span> in a pill taken twice daily. While it sounds great, it may not be the perfect fit for you. <\/span>Side effects<\/span> from either component drug could have you searching for other options, or your other medications or health problems may prohibit <\/span>Synjardy<\/span>\u2019s use. Since <\/span>Synjardy<\/span> is only available as a <\/span>brand name<\/span> product and may not have preferred <\/span>formulary<\/span><\/a> status with your <\/span>insurance coverage<\/span>, cost concerns are another reason you may need an alternative. Whatever your reason for wanting to know about <\/span>Synjardy<\/span> alternatives, read on to familiarize yourself with a few, and then talk to your <\/span>healthcare provider<\/span> about your ideas.<\/span><\/p>\n

What can I take in place of <\/span>Synjardy<\/span>?<\/span><\/h2>\n

Metformin<\/span><\/a> is a <\/span>biguanide<\/span><\/a>, aimed at lowering <\/span>blood glucose<\/span> levels by reducing the liver\u2019s production of <\/span>glucose<\/span> and increasing body tissue\u2019s utilization of <\/span>glucose<\/span>. <\/span>Empagliflozin<\/span> is a <\/span>sodium-glucose cotransporter 2<\/span> (SGLT2) inhibitor<\/span><\/a>, which reduces <\/span>blood sugar levels<\/span> by enhancing the excretion of <\/span>glucose<\/span> in the urine. Putting those two mechanisms together in <\/span>Synjardy<\/span> can provide a powerful treatment for <\/span>Type 2 diabetes<\/span>. However, it is not the only diabetic combination pill, and they are not the only diabetic <\/span>drug classes<\/span> that are available in such combinations. Dipeptidyl peptidase-4 (<\/span>DPP-4<\/span>) inhibitors and <\/span>sulfonylureas<\/span><\/a> are often coupled with <\/span>metformin<\/span> too. Even a couple of injectable <\/span>glucagon-like peptide-1 (GLP-1) <\/span>agonists<\/span><\/a> are found in dual mechanism products, combined with insulin. Let\u2019s look over the list of some options for you to consider and then delve into greater detail on a few common ones.<\/span><\/p>\n

RELATED: <\/b>What are normal <\/b>blood sugar levels<\/b>?<\/b><\/a><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Compare Synjardy alternatives<\/span><\/h2>\n<\/th>\n<\/tr>\n<\/thead>\n

Drug name<\/b><\/td>\nUses<\/b><\/td>\nDosage<\/b><\/td>\nSavings options<\/b><\/td>\n<\/tr>\n
Synjardy (empagliflozin\/metformin)<\/td>\nType 2 diabetes mellitus<\/td>\n5 mg\/500 mg to 12.5 mg\/1000 mg twice daily<\/td>\nSynjardy coupons<\/a><\/td>\n<\/tr>\n
Synjardy XR (empagliflozin\/metformin ER)<\/td>\nType 2 diabetes mellitus<\/td>\n5 mg\/1000 mg to 25 mg\/1000 mg once daily<\/td>\nSynjardy XR coupons<\/a><\/td>\n<\/tr>\n
Jardiance (empagliflozin)<\/td>\nType 2 diabetes mellitus, cardiovascular event risk reduction in Type 2 diabetes mellitus, heart failure risk reduction in those with reduced cardiac ejection fractions<\/td>\n10-25 mg once daily<\/td>\nJardiance coupons<\/a><\/td>\n<\/tr>\n
Metformin<\/td>\nType 2 diabetes mellitus, polycystic ovarian syndrome (off-label<\/a>)<\/td>\n500-1000 mg twice daily<\/td>\nMetformin coupons<\/a><\/td>\n<\/tr>\n
Glyxambi (empagliflozin\/linagliptin)<\/td>\nType 2 diabetes mellitus<\/td>\n10 mg\/5 mg to 25 mg\/5 mg once daily<\/td>\nGlyxambi coupons<\/a><\/td>\n<\/tr>\n
Trijardy XR (empagliflozin\/linagliptin\/metformin ER)<\/td>\nType 2 diabetes mellitus<\/td>\n5 mg\/2.5 mg\/1000 mg to 25 mg\/5 mg\/1000 mg once daily<\/td>\nTrijardy XR coupons<\/a><\/td>\n<\/tr>\n
Janumet (sitagliptin\/metformin)<\/td>\nType 2 diabetes mellitus<\/td>\n50 mg\/500 mg to 50 mg\/1000 mg twice daily<\/td>\nJanumet coupons<\/a><\/td>\n<\/tr>\n
Trulicity (dulaglutide)<\/td>\nType 2 diabetes mellitus, cardiovascular event risk reduction in those with Type 2 diabetes and cardiovascular disease or multiple risk factors<\/td>\n0.75-4.5 mg subcutaneous (under the skin) injection once weekly<\/td>\nTrulicity coupons<\/a><\/td>\n<\/tr>\n
Ozempic (semaglutide)<\/td>\nType 2 diabetes mellitus, cardiovascular event risk reduction in those with Type 2 diabetes and cardiovascular disease<\/td>\n0.5-1 mg subcutaneous injection once weekly<\/td>\nOzempic coupons<\/a><\/td>\n<\/tr>\n
Rybelsus (semaglutide)<\/td>\nType 2 diabetes mellitus<\/td>\n7-14 mg once daily<\/td>\nRybelsus coupons<\/a><\/td>\n<\/tr>\n
Victoza (liraglutide)<\/td>\nType 2 diabetes mellitus, cardiovascular event risk reduction in those with Type 2 diabetes and cardiovascular disease<\/td>\n1.2-1.8 mg subcutaneous injection once daily<\/td>\nVictoza coupons<\/a><\/td>\n<\/tr>\n
Mounjaro (tirzepatide)<\/td>\nType 2 diabetes mellitus<\/td>\n5-15 mg subcutaneous injection once weekly<\/td>\nMounjaro coupons<\/a><\/td>\n<\/tr>\n
Farxiga (dapagliflozin)<\/td>\nType 2 diabetes mellitus, heart failure risk reduction in Type 2 diabetes mellitus with heart disease or multiple cardiovascular risk factors, heart failure risk reduction in those with reduced cardiac ejection fractions, heart failure and kidney disease progression risk reduction in those with chronic renal disease<\/td>\n5-10 mg once daily<\/td>\nFarxiga coupons<\/a><\/td>\n<\/tr>\n
Xigduo XR (dapagliflozin\/metformin extended-release [ER])<\/td>\nType 2 diabetes mellitus<\/td>\n2.5 mg\/1000 mg to 10 mg\/1000 mg once daily<\/td>\nXigduo XR coupons<\/a><\/td>\n<\/tr>\n
Lantus Solostar (insulin glargine)<\/td>\nType 2 diabetes mellitus, Type 1 diabetes mellitus<\/td>\nIndividualized dose injected subcutaneously once daily<\/td>\nLantus Solostar coupons<\/a><\/td>\n<\/tr>\n
Soliqua (insulin glargine\/lixisenatide)<\/td>\nType 2 diabetes mellitus<\/td>\n15 to 60 units injected subcutaneously once daily<\/td>\nSoliqua coupons<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Other alternatives to <\/span>Synjardy<\/span><\/h3>\n